The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: Initial first in man clinical results
- 1 November 2015
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 199, 18-24
- https://doi.org/10.1016/j.ijcard.2015.06.111
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- The effect of a peptide-modified thermo-reversible methylcellulose on wound healing and LV function in a chronic myocardial infarction rodent modelBiomaterials, 2013
- Augmentation of Left Ventricular Wall Thickness With Alginate Hydrogel Implants Improves Left Ventricular Function and Prevents Progressive Remodeling in Dogs With Chronic Heart FailureJACC: Heart Failure, 2013
- Beneficial effects of the CorCap cardiac support device: Five-year results from the Acorn TrialThe Journal of Thoracic and Cardiovascular Surgery, 2012
- National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008JAMA, 2011
- Worldwide surgical experience with the Paracor HeartNet cardiac restraint deviceThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Initial Safety and Feasibility Clinical Trial of the Myosplint DeviceJournal of Cardiac Surgery, 2005
- Acute reduction of ventricular volume decreases QT interval dispersion in elderly subjects with and without heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with Six-Month Follow-UpJournal of the American College of Cardiology, 2003
- Left Ventricular Remodeling and Ventricular Arrhythmias After Myocardial InfarctionCirculation, 2003
- HEART FAILURE: Epidemiology, aetiology, and prognosis of heart failureHeart, 2000